The effects of congenital adrenal hyperplasia on adult height and fertility were studied in 30 afflicted men. The patients' heights ranged from 150.0 to 178.6 cm (mean +/- 1 S.D. of 164.0 +/- 7.6), which is significantly lower than both the mean adult height for American men and that of the patients' parents (P less than 0.005). There was no correlation between adult height and the age at which therapy was begun, possibly because the patients treated before one year of age had the salt-losing form of the syndrome. Therapeutic compliance may also have been involved. Apparently normal fertility, indicated by paternity and normal sperm counts, was found in 18 out of 20 patients evaluated. This group included five untreated patients who were found to be fertile and to have normal plasma testosterone and gonadotropin but elevated androstenedione levels.
This article has been cited by other articles:
Bonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., Schwarz, H. P.
(2009). Hydrocortisone Dosing during Puberty in Patients with Classical Congenital Adrenal Hyperplasia: An Evidence-Based Recommendation. J. Clin. Endocrinol. Metab.
94: 3882-3888
[Abstract][Full Text]
Bonfig, W., Bechtold, S., Schmidt, H., Knorr, D., Schwarz, H. P.
(2007). Reduced Final Height Outcome in Congenital Adrenal Hyperplasia under Prednisone Treatment: Deceleration of Growth Velocity during Puberty. J. Clin. Endocrinol. Metab.
92: 1635-1639
[Abstract][Full Text]
New, M. I.
(2006). Nonclassical 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
91: 4205-4214
[Abstract][Full Text]
Balsamo, A., Cicognani, A., Baldazzi, L., Barbaro, M., Baronio, F., Gennari, M., Bal, M., Cassio, A., Kontaxaki, K., Cacciari, E.
(2003). CYP21 Genotype, Adult Height, and Pubertal Development in 55 Patients Treated for 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
88: 5680-5688
[Abstract][Full Text]
Speiser, P. W., White, P. C.
(2003). Congenital Adrenal Hyperplasia. NEJM
349: 776-788
[Full Text]
Tiitinen, A., Valimaki, M.
(2002). Primary Infertility in 45-Year-Old Man with Untreated 21-Hydroxylase Deficiency: Successful Outcome with Glucocorticoid Therapy. J. Clin. Endocrinol. Metab.
87: 2442-2445
[Abstract][Full Text]
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., Wilson, R. C.
(2001). EXTENSIVE PERSONAL EXPERIENCE: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 532 Pregnancies. J. Clin. Endocrinol. Metab.
86: 5651-5657
[Abstract][Full Text]
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., Hermus, A. R. M. M.
(2001). High Prevalence of Testicular Adrenal Rest Tumors, Impaired Spermatogenesis, and Leydig Cell Failure in Adolescent and Adult Males with Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab.
86: 5721-5728
[Abstract][Full Text]
Cabrera, M. S., Vogiatzi, M. G., New, M. I.
(2001). Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab.
86: 3070-3078
[Abstract][Full Text]
Bruining, H., Bootsma, A. H., Koper, J. W., Bonjer, J., de Jong, F. H., Lamberts, S. W. J.
(2001). Fertility and Body Composition after Laparoscopic Bilateral Adrenalectomy in a 30-Year-Old Female with Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab.
86: 482-484
[Abstract][Full Text]
White, P. C., Speiser, P. W.
(2000). Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocr. Rev.
21: 245-291
[Abstract][Full Text]
Van de Velde, H., Sermon, K., De Vos, A., Lissens, W., Joris, H., Vandervorst, M., Van Steirteghem, A., Liebaers, I.
(1999). Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia. Mol Hum Reprod
5: 691-696
[Abstract][Full Text]
Russo, G., Paesano, P., Taccagni, G., Del Maschio, A., Chiumello, G.
(1998). Ovarian Adrenal-Like Tissue in Congenital Adrenal Hyperplasia. NEJM
339: 853-854
[Full Text]
Gussinye, M., Carrascosa, A., Potau, N., Enrubia, M., Vicens-Calvet, E., Ibanez, L., Yeste, D.
(1997). Bone Mineral Density in Prepubertal and in Adolescent and Young Adult Patients With the Salt-wasting Form of Congenital Adrenal Hyperplasia. Pediatrics
100: 671-674
[Abstract][Full Text]
Silva, I. N., Kater, C. E., Cunha, C. d. F., Viana, M. B.
(1997). Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch. Dis. Child.
77: 214-218
[Abstract][Full Text]
LaFranchi, S.
(1980). Plasma Adrenocorticotrophic Hormone in Congenital Adrenal Hyperplasia: Importance in Long-term Management. Arch Pediatr Adolesc Med
134: 1068-1072
[Abstract]
Previous
